semaglutide effect on dopamine GLP-1 Medications: A Game Changer for Brain Health Beyond Weight Loss Semaglutide reduces alcohol intake and

[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Seino Y, Fukushima M, Yabe D

Zepbound (tirzepatide), a dual GIP and GLP-1 receptor agonist, can cause gastrointestinal side effects including belching with a distinctive sulfurous odor

Clinical guidelines recommend 8-12 weeks of consistent semaglutide use at progressively adjusted doses before determining non-response

Coupling it with a protein-rich meal or snack buffers gastric acid, reduces reflux risk, and stabilises blood sugar fluctuations, improving gastrointestinal comfort

Scientists are also working to identify specific biological markers, genetic or metabolic traits, that could help determine which patients will benefit most from these treatments

Research Highlights: Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer cardiac events, fewer emergency department visits and a decreased mortality